Pharmacy and the U.S. Health Care System, Third EditionCRC Press, 2005 M07 22 - 476 pages The healthcare field is rapidly evolving, compelled by technological strides, pressure to increase efficiency, and demand to contain costs. Pharmacy and the U.S. Health Care System, Third Edition is the classic text used to prepare pharmacists for independent practice in today's unpredictable environment since the first edition was published in 1991. This new edition is now streamlined and tailored for a one-semester course, completely updated with the most recent data, statistics, and emerging issues relevant to today's pharmacy professional, with new chapters devoted to the political realities of the industry and the future of pharmacy. |
From inside the book
Results 1-5 of 88
Page ix
... Klimas Richard G. Stefanacci Demographics of the Elderly Population Demand for Health Care Services Special Considerations in the Provision of Health Care to the Elderly 193 196 197 Long - Term Care 201 Nursing Facilities 203 The Role.
... Klimas Richard G. Stefanacci Demographics of the Elderly Population Demand for Health Care Services Special Considerations in the Provision of Health Care to the Elderly 193 196 197 Long - Term Care 201 Nursing Facilities 203 The Role.
Page x
Michael Smith. Long - Term Care 201 Nursing Facilities 203 The Role of the Geriatric Pharmacist in Other Senior Settings 210 Future Payer Initiatives 217 Conclusion 218 Chapter 11. The Pharmaceutical Research Manufacturing Industry 227 ...
Michael Smith. Long - Term Care 201 Nursing Facilities 203 The Role of the Geriatric Pharmacist in Other Senior Settings 210 Future Payer Initiatives 217 Conclusion 218 Chapter 11. The Pharmaceutical Research Manufacturing Industry 227 ...
Page 10
Sorry, this page's content is restricted.
Sorry, this page's content is restricted.
Page 15
Sorry, this page's content is restricted.
Sorry, this page's content is restricted.
Page 16
Sorry, this page's content is restricted.
Sorry, this page's content is restricted.
Contents
V | 1 |
VI | 6 |
VII | 9 |
VIII | 12 |
IX | 17 |
X | 18 |
XI | 21 |
XII | 23 |
LXXVI | 210 |
LXXVII | 217 |
LXXVIII | 218 |
LXXIX | 227 |
LXXX | 229 |
LXXXI | 232 |
LXXXII | 233 |
LXXXIII | 235 |
XIII | 29 |
XIV | 35 |
XV | 41 |
XVI | 43 |
XVII | 44 |
XVIII | 46 |
XIX | 49 |
XX | 54 |
XXI | 58 |
XXII | 61 |
XXIII | 62 |
XXIV | 65 |
XXV | 68 |
XXVI | 74 |
XXVIII | 76 |
XXIX | 78 |
XXX | 81 |
XXXI | 84 |
XXXII | 88 |
XXXIII | 92 |
XXXIV | 93 |
XXXV | 94 |
XXXVI | 108 |
XXXVII | 113 |
XXXIX | 117 |
XL | 118 |
XLI | 129 |
XLII | 130 |
XLIII | 133 |
XLIV | 134 |
XLV | 141 |
XLVI | 143 |
XLVII | 145 |
XLVIII | 147 |
XLIX | 148 |
L | 149 |
LI | 150 |
LII | 153 |
LIII | 155 |
LV | 158 |
LVI | 160 |
LVII | 161 |
LVIII | 163 |
LX | 169 |
LXI | 171 |
LXII | 173 |
LXIII | 174 |
LXIV | 178 |
LXV | 180 |
LXVI | 184 |
LXVII | 186 |
LXVIII | 187 |
LXIX | 188 |
LXX | 189 |
LXXI | 193 |
LXXII | 196 |
LXXIII | 197 |
LXXIV | 201 |
LXXV | 203 |
LXXXIV | 236 |
LXXXV | 237 |
LXXXVI | 239 |
LXXXVII | 240 |
LXXXVIII | 241 |
LXXXIX | 243 |
XC | 244 |
XCI | 246 |
XCII | 247 |
XCIII | 248 |
XCIV | 249 |
XCV | 253 |
XCVI | 254 |
XCVII | 255 |
XCVIII | 258 |
XCIX | 260 |
C | 264 |
CI | 275 |
CII | 283 |
CIII | 290 |
CIV | 297 |
CV | 298 |
CVI | 299 |
CVII | 300 |
CVIII | 313 |
CIX | 316 |
CX | 325 |
CXI | 326 |
CXII | 344 |
CXIV | 345 |
CXVI | 346 |
CXVII | 351 |
CXVIII | 353 |
CXIX | 357 |
CXXI | 358 |
CXXII | 364 |
CXXIII | 374 |
CXXIV | 376 |
CXXV | 380 |
CXXVI | 385 |
CXXVII | 389 |
CXXVIII | 403 |
CXXIX | 404 |
CXXX | 405 |
CXXXI | 406 |
CXXXII | 408 |
CXXXIII | 409 |
CXXXIV | 411 |
CXXXV | 412 |
CXXXVI | 414 |
CXXXVII | 415 |
CXXXVIII | 417 |
CXL | 418 |
CXLI | 423 |
CXLII | 430 |
CXLIII | 439 |
445 | |
Other editions - View all
Common terms and phrases
activities Administration American antibodies Available online behavior benefit Biotechnology Biotechnology Industry Organization cells Center changes chronic cists clinical pharmacy Colleges of Pharmacy community pharmacy consultant pharmacist consumers cost coverage cultural cytokines decision diffusion of innovations disease dispensing drug therapy effects elderly employees factors federal gene gene therapy genetic genomics geriatric health care providers health care system health insurance health professions health services Health-System Hispanic HMOs hospital Ibid increase individual industry innovations interactions interferons issues Journal macists macy managed managed care manufacturers Medicaid Medicare medications Medicine monoclonal antibodies National noncompliance nursing home outcomes PBMs percent phar pharma Pharmaceutical Association Pharmacogenetics pharmacy organizations pharmacy practice pharmacy services physician plans population practitioners prescribing prescription drugs problems professional programs protein reimbursement response role social technicians therapeutic tion treatment U.S. Census Bureau U.S. Department U.S. health United utilization vaccines workforce